Delivery Order SPE2DB24D8001-SPE2DB25FLAGW
- Not listed
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, received a delivery order award from the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count). This firm fixed-price delivery order, valued at $1,184.05, is expected to be completed by July 31, 2025, and represents performance at the vendor's Anoka, Minnesota location. The award carries no set-aside designation and operates under Dakota Drug's larger...
- The Defense Logistics Agency awarded a $1,391.42 firm fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of 90 tablets of Jardiance 25 mg. The award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation. This delivery order is issued under Dakota Drug, Inc.'s larger single-award Indefinite Delivery Contract (SPE2DB24D8001) valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $2.74K delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Jardiance 25 mg tablets (90-count units). Issued on August 19, 2025, with completion scheduled for August 20, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract contains no...
- The Defense Logistics Agency awarded a delivery order valued at $1,426.86 to Dakota Drug, Inc. for the supply of Jardiance 25 mg tablets (90-count units) with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-set-aside procurement executed through Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program. The contract is valued at up to $999,999,999.00 and runs through...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.04 to Dakota Drug, Inc. for the supply of Jardiance 10 mg tablets (90-count) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a continuation of pharmaceutical supply services under the company's larger indefinite delivery contract with DLA Troop Support Medical's ECAT Generation V Program (SPE2DB24D8001), valued at $999,999,999.00 through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,703.89 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a period of performance through November 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,094.61 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Jardiance 25 mg tablets. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,766.92, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract is a firm-fixed-price delivery order, with an ultimate completion date of July 18, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Armed...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,045.60, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a performance period extending through January 14, 2025. Dakota Drug, Inc. is a critical supplier for the DLA Troop Support Medical division, holding a significant $999,999,999.00 Indefinite Delivery Contract (IDC) as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,042.91, is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price, unrestricted delivery order with a period of performance through March 3, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLAGWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,985.04 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, on August 21, 2025. The order covers 90 tablets of Jardiance 25 mg, a diabetes management medication, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a continuation of Dakota Drug's pharmaceutical supply support to the federal government. This delivery order falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, a $999,999,999.00 comprehensive vehicle supporting U.S. Armed Forces medical operations through December 31, 2025. The contract enables Dakota Drug to supply a broad range of pharmaceutical products, medical supplies, and healthcare equipment to military healthcare facilities. The company has demonstrated extensive capability in delivering critical medications including diabetes management products, respiratory treatments, pain management drugs, and vaccines, establishing itself as a strategic vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/21/25 |